論文（英文）
Ebata S, Yoshizaki A, Oba K, Kashiwabara K, Ueda K, Uemura Y, Watadani T, Fukasawa T, Miura S, Yoshizaki-Ogawa A, Asano Y, Okiyama N, Kodera M, Hasegawa M, Sato S. Safety and efficacy of rituximab in systemic sclerosis: a double-blind, parallel-group comparison, investigators initiated confirmatory clinical trial (DESIRES). Lancet Rheumatol. 2021; 3(7): E489-E497. https://doi.org/10.1016/S2665-9913(21)00107-7
Ebata S, Yoshizaki A, Oba K, Kashiwabara K, Ueda K, Uemura Y, Watadani T, Fukasawa T, Miura S, Yoshizaki-Ogawa A, Asano Y, Okiyama N, Kodera M, Hasegawa M, Sato S. Safety and efficacy of rituximab in systemic sclerosis: a double-blind, parallel-group comparison, investigators initiated confirmatory clinical trial (DESIRES). Lancet Rheumatol. 2021; 3(7): E489-E497. https://doi.org/10.1016/S2665-9913(21)00107-7